• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Oncorus Inc.

    8/7/23 6:52:07 AM ET
    $ONCR
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $ONCR alert in real time by email
    DEFA14A 1 oncr_-_defa14a_8.7.23.htm DEFA14A DEFA14A

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    ______________________

     

    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934

    (Amendment No.__)

    ______________________

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

    ☐ Preliminary Proxy Statement

    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐ Definitive Proxy Statement

    ☒ Definitive Additional Materials

    ☐ Soliciting Material Pursuant to § 240.14a-12

    ONCORUS, INC.

    (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement if other than the Registrant)

    Payment of Filing Fee (Check all boxes that apply):

    ☒ No fee required.

    ☐ Fee paid previously with preliminary materials

    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

     

     


     

    img226316782_0.jpg 

     

    img226316782_1.jpg 

     

     

     

    August 4, 2023

     

    Address1

    Address2

    Address3

    Address4

    Address5

    Address6

    Address7

    Barcode

     

    URGENT – YOUR PARTICIPATION IS REQUIRED!

     

    Insert QR CODE here

     

    Re: Your investment in Oncorus, Inc.

     

    Dear Stockholder,

     

    We have been trying to reach you on behalf of Oncorus, Inc. We are acting as proxy solicitor for Oncorus’ Special Meeting of Stockholders, which has been adjourned until August 18th, 2023, to give stockholders additional time to cast their votes.

     

    The Special Meeting has been called to vote on the dissolution and liquidation of Oncorus. You are eligible to vote at the Special Meeting because you held Oncorus common stock as of the record date for the Special Meeting, June 8, 2023. You are eligible to vote even if you do not hold Oncorus common stock today. The company will not be in a position to make cash distributions unless and until the dissolution proposal is approved by stockholders of record. Please refer to the previously distributed proxy materials for disclosures regarding the dissolution proposal, estimated distributions to stockholders following dissolution and assumptions underlying such estimates. The proxy materials are available on the SEC’s website at www.sec.gov.

     

    Please contact us immediately at 1-855-601-2246 between the hours of 9:00am and 10:00pm Eastern time, Monday through Friday and Saturday and Sunday from 10:00am to 6:00pm or please scan the QR Code above and follow the prompts provided to vote your account. You may also email us at [email protected].

     

    This matter is very important and will only take a moment of your time.

     

    Thank you in advance for your assistance with this matter.

     

    Sincerely,

    Gina Balderas

    Operations Manager

     


    Get the next $ONCR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ONCR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ONCR
    SEC Filings

    See more
    • SEC Form DEFA14A filed by Oncorus Inc.

      DEFA14A - Oncorus, Inc. (0001671818) (Filer)

      8/7/23 6:52:07 AM ET
      $ONCR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 15-12G filed by Oncorus Inc.

      15-12G - Oncorus, Inc. (0001671818) (Filer)

      8/3/23 5:00:26 PM ET
      $ONCR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form DEFA14A filed by Oncorus Inc.

      DEFA14A - Oncorus, Inc. (0001671818) (Filer)

      7/28/23 4:40:36 PM ET
      $ONCR
      Medicinal Chemicals and Botanical Products
      Health Care